My personal commitment to the cancer battle started with a personal story, as it does for so many. I lost my mother to cancer when she was just 45, and I was determined to do what I could to help avoid this kind of loss for other families.
I became involved with Dana-Farber about 30 years ago, working with a team of senior faculty to explore ways to attract commercial funding to support early stage research. That effort led to a partnership between the Institute and the company now called Novartis, that continues today.
Several decades into my engagement with the Institute, I am more confident than ever that this is the right place for me to contribute my energy and resources: I believe Dana-Farber has the deepest research and clinical development expertise, and the most caring and committed people, focused on cancer anywhere in the world.